PAHC 28.15 Phibro Animal Health Corp $PAHC Hit a 52 week

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
PAHC 28.15 Phibro Animal Health Corp $PAHC Hit a 52 week high of 28.15 Currently at 28.15 +0.34 +1.22% With a day low of 28.12 and a total volume of 346.

PAHC Phibro Animal Health Corp Recent Headline News

Phibro Animal Health Corporation declares $0.10 dividend
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 4:00PM CST

PAHC: 28.02 (+0.21)

Phibro Animal Health Corporation Declares Quarterly Dividend
GlobeNewswire - Mon Nov 10, 3:15PM CST
The Board of Directors of Phibro Animal Health Corporation (Nasdaq AHC) today declared a quarterly cash dividend of $0.10 per share on its Class A common stock and Class B common stock, payable on December 23, 2014, to stockholders of record at the close of business on December 3, 2014.
PAHC: 28.02 (+0.21)

Netflix and Gilead Will See More Gains, Says Thornburg Value Manager
at The Street - Thu Oct 30, 4:54PM CDT
Gilead shares have had a tremendous run this year, but the valuation remains cheap considering its sales potential in the area of Hepatitis C.
NFLX: 388.55 (+1.28), PAHC: 28.02 (+0.21), GILD: 108.21 (+1.19)

Weakness Seen in Trinity Biotech (TRIB): Stock Tumbles 7.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Oct 24, 7:44AM CDT
Shares of Trinity Biotech fell nearly 8% last session and witnessed flat revision in current year estimates in the past few weeks suggest a close watch of the firm in the near future.
ZLTQ: 27.27 (-0.39), PAHC: 28.02 (+0.21), GWPH: 74.61 (+0.66), TRIB: 17.89 (+0.24)

Can the Uptrend Continue for Phibro Animal Health (PAHC)? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Oct 14, 8:29AM CDT
Can the Uptrend Continue for Phibro Animal Health (PAHC)?
PAHC: 28.02 (+0.21)

Phibro Animal Health Corporation to Host Webcast and Conference Call on September 2014 Quarterly Financial Results
GlobeNewswire - Fri Oct 10, 1:04PM CDT
Phibro Animal Health Corporation (Nasdaq AHC) will host a webcast and conference call to review first quarter financial results. A news release containing quarterly results is expected to be issued after the market closes on November 11, 2014.
PAHC: 28.02 (+0.21)

Dairy: The Future Of Protein - Global Markets, Competitors And Opportunities - 2014-2019 Analysis And Forecasts
M2 - Mon Oct 06, 9:25AM CDT
Research and Markets (http://www.researchandmarkets.com/research/w9wq33/dairy_the) has announced the addition of the "Dairy: The Future Of Protein - Global Markets, Competitors And Opportunities - 2014-2019 Analysis And Forecasts" report to their offering. The long-term thesis supporting the market for protein is hard to ignore: more people equals more mouths to feed, while the shift in diets, notably among emerging markets, will drive increased demand for protein of all types. This implies a substantial revenue opportunity for those facilitating the procurement, trading, storage, and transportation of protein products. This report focuses on Dairy protein only, whose production is estimated at USD354.4 billion in 2014, and is forecast to grow more than 10% annually over the next five years. Topics covered in the report include global protein production by class and type, dairy production by type and region, dairy retail sales, exports, imports, foreign markets, the feed outlook, alfalfa production, yogurt demand and the Chinese infant milk formula market, among others. The report contains detailed analysis of the major dairy market players in terms of their product offerings, markets served, strategies, competitors and financial performance. In addition to profiles of 34 public companies involved in the dairy industry, the report also contains 78 tables and 125 figures. Key Topics Covered: 1. Introduction 2. Executive Summary 3. Protein Overview 4. Protein Market Overview 5. Dairy Protein Market Companies Mentioned: - AGCO Corporation - Archer Daniels Midland Company - Balchem Corporation - Beingmate Baby & Child Food - Biostime International - Bunge Limited - China Mengniu Dairy Company Limited - China Modern Dairy Holdings - Chr. Hansen Holding - Dairy Crest Group - Danone - Dean Foods Company - Deere & Company - Dupont E I De Nemours & Co - Emmi - Farmland Partners Inc. - Fonterra Co-operative Group Limited - General Mills - Glanbia plc - Gloria SA - Kraft Foods Group - Mead Johnson Nutrition Company - Megmilk Snow Brand - Meiji Holdings - Monsanto - Morinaga Milk Industry - Nestle SA - Phibro Animal Health - Ridley Inc.. - S&W Seed Company - Syngenta - Synlait Milk Limited - Synutra International - Yakult Honsha - Yili Group For more information visit http://www.researchandmarkets.com/research/w9wq33/dairy_the
KRFTV: 44.10 (-0.53), SANW: 3.65 (+0.01), PAHC: 28.02 (+0.21), FPI: 10.54 (-0.12), AGCO: 45.13 (-0.11), SYUT: 6.32 (-0.59), BCPC: 68.66 (+2.93), BG: 89.02 (+0.27), MJN: 98.81 (-0.51), ADM: 50.87 (+0.10), DE: 88.35 (-0.19), DF: 16.27 (-0.13), GIS: 50.87 (unch)

The Zacks Analyst Blog Highlights: Super Micro Computer, Horizon Pharma, Phibro Animal Health, Seattle Genetics and Takeda Pharmaceutical
PR Newswire - Thu Oct 02, 8:30AM CDT
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Super Micro Computer, Inc. (Nasdaq:SMCI-Free Report), Horizon Pharma plc (Nasdaq:HZNP-Free Report), Phibro Animal Health Corp. (Nasdaq AHC-Free Report), Seattle Genetics, Inc. (Nasdaq:SGEN-Free Report) and Takeda Pharmaceutical Company Ltd. (OTC:TKPYY-Free Report).
SMCI: 33.98 (+0.28), SGEN: 37.14 (+0.24), PAHC: 28.02 (+0.21), HZNP: 13.04 (+0.12)

3 Best Performing Stocks in September - Analyst Blog
Swarup Gupta - Zacks Investment Research - Wed Oct 01, 3:01PM CDT
International headwinds dragged down the markets in September as all the benchmarks took losses over the month.
SMCI: 33.98 (+0.28), PAHC: 28.02 (+0.21), HZNP: 13.04 (+0.12)

Phibro Animal Health Corporation Reports Fourth Quarter and Annual Results
GlobeNewswire - Tue Sep 16, 4:26PM CDT
Phibro Animal Health Corporation (Nasdaq AHC) today announced its financial results for its fourth quarter and fiscal year ended June 30, 2014. It also provided guidance for its fiscal year ending June 30, 2015.
PAHC: 28.02 (+0.21)

Phibro Animal Health Corporation to Participate in Morgan Stanley's 2014 Global Healthcare Unplugged Conference
GlobeNewswire - Wed Aug 13, 4:30PM CDT
Phibro Animal Health Corporation (Nasdaq AHC) Chairman, President and Chief Executive Officer Jack Bendheim and Chief Financial Officer Richard Johnson will address financial analysts and investors at the Morgan Stanley 2014 Global Healthcare Unplugged Conference.
PAHC: 28.02 (+0.21), MS: 35.83 (-0.05)

Phibro Animal Health Corporation to Host Webcast and Conference Call on Fourth Quarter and Fiscal Year 2014 Results
GlobeNewswire - Fri Aug 08, 3:00PM CDT
Phibro Animal Health Corporation (Nasdaq AHC) will host a webcast and conference call to review fourth quarter and fiscal year 2014 financial results, discuss fiscal year 2015 financial guidance and respond to questions from investors. A news release containing quarterly and fiscal year results is expected to be issued after the market closes on September 16, 2014.
PAHC: 28.02 (+0.21)

Will Fiscal 2015 Growth Plans Help in Campbell's Turnaround? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jul 22, 5:00PM CDT
Campbell Soup Company (CPB) revealed its growth plans for fiscal 2015 as well as the actions that are being taken to revive its business.
PAHC: 28.02 (+0.21), THS: 80.49 (+0.47), CPB: 44.33 (-0.06), PF: 33.39 (-0.15)

SUPERVALU (SVU) Jumps: Stock Rises 7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jul 17, 8:04AM CDT
SUPERVALU Inc. (SVU) was a big mover last session, as the company saw its shares rise over 7% on the day.
PAHC: 28.02 (+0.21), SVU: 8.69 (-0.01), THS: 80.49 (+0.47), BRFS: 25.01 (-0.18)

Diamond Foods to Grow on Turnaround Strategies - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jul 09, 4:35PM CDT
On Jul 3, 2014, we issued an updated research report on Diamond Foods (DMND).
HAIN: 106.08 (-3.13), DMND: 30.73 (+0.13), PAHC: 28.02 (+0.21), THS: 80.49 (+0.47)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 145

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 213

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 25

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 106

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 208

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
Master Sommeliers and Italian Producers Clash on Wine Lists

Updated Category News Views 166

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 231

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 266

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 270

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 48

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading

Top 5 Most Recently Viewed Articles

VENU Embraces Blockchain: A New Era for Live Events

Updated Category News Views 203

VENU's Groundbreaking Blockchain Initiative in Live Entertainment In a significant move that signals the future of live entertainment, VENU (NYSE American: VENU), a leading operator of premium venues across the country, has announced an innovative blockchain-powered platform set to launch in 2026. This strategy is revolutionary, intending to blend physical experiences...

Continue Reading
Empowering Leadership Transitions at Ora Enhance Customer Focus

Updated Category News Views 144

Empowering Strategic Leadership at Ora Ora, an esteemed player in the field of ophthalmic contract research organizations (CROs), has recently appointed Cindy Markham as its new Chief Commercial Officer. This strategic move underscores Ora's dedication to enhancing the customer experience, setting a new benchmark in the ophthalmic research sector. Commitment to Customer...

Continue Reading
Real Matters Announces Online Annual General Meeting Details

Updated Category News Views 166

Virtual Annual General Meeting Scheduled for Shareholders Real Matters Inc., a prominent network management services provider, has announced the date for its upcoming Annual General Meeting (AGM). The meeting is set to take place on a Thursday morning, providing a convenient option for shareholders to participate from the comfort of their homes. Accessing the AGM Online...

Continue Reading
Trinity Biotech Triumphs in Nasdaq Compliance Journey

Updated Category News Views 41

Trinity Biotech Celebrates Nasdaq Compliance Achievement Trinity Biotech plc (Nasdaq Global Select: TRIB), a leading name in biotechnology focused on human diagnostics and diabetes management solutions, including innovative wearable biosensors, has reached a significant milestone. The company recently announced it has regained compliance with the minimum market value of...

Continue Reading
Vaycaychella Transitions to Great Estate Blockchains Inc

Updated Category News Views 176

Vaycaychella Unveils a Bold New Identity Vaycaychella, Inc. (OTC Pink: VAYK) has officially announced a name change to "Great Estate Blockchains Inc." This transition signifies a rejuvenated focus on enhancing the value of historic landmarks through innovative cryptocurrency strategies. The company aims to tap into a colossal market, potentially valued in the hundreds of...

Continue Reading